← Back to headlines
Eli Lilly Explores Pain Management Strategy with New Biotech Acquisition
Eli Lilly and Company is reportedly strengthening its pain management strategy through a new acquisition of a biotech firm.
24 Jun, 13:26 — 24 Jun, 13:26
Sources
Showing 1 of 1 sources
Related Stories
Italy Extends Diesel Fuel Tax Cut Through Early September
17m ago
Cisco Abandons Traditional Hardware Restrictions to Pursue AI Infrastructure Boom
27m ago
Executives at Itron and Lyft Sell Significant Company Stock Holdings
29m ago
Senior Official Firmly Rejects External Political Pressure and Influence Attempts
29m ago